Latest Ratios: P/E Ratio 21.9x · EV/EBITDA 14.2x · ROE 25.5%. (1997–2026 historical series)
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
| Metric | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $11.7B | $11.5B | $14.3B | $16.3B | $17.0B | $16.8B | $14.7B | $13.5B | $10.6B | $9.0B | $6.2B |
| Enterprise Value | $13.0B | $12.8B | $15.6B | $17.5B | $18.4B | $18.5B | $14.8B | $13.8B | $10.8B | $9.4B | $6.6B |
| P/E Ratio → | 21.86 | 21.52 | 24.01 | 30.40 | 36.25 | 42.28 | 36.70 | 36.31 | 29.97 | 33.83 | 24.14 |
| P/S Ratio | 4.87 | 4.74 | 6.33 | 7.64 | 8.41 | 9.28 | 9.26 | 9.12 | 7.46 | 6.77 | 5.14 |
| P/B Ratio | 6.00 | 5.73 | 6.55 | 8.54 | 10.48 | 12.61 | 14.43 | 15.08 | 15.73 | 17.18 | 11.13 |
| P/FCF | 16.48 | 16.23 | 23.21 | 26.57 | 29.03 | 34.46 | 29.69 | 31.62 | 28.76 | 25.65 | 21.97 |
| P/OCF | 14.18 | 13.96 | 19.73 | 23.32 | 26.30 | 31.18 | 26.41 | 26.77 | 24.76 | 23.42 | 19.44 |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 5.28 | 6.86 | 8.18 | 9.11 | 10.23 | 9.38 | 9.32 | 7.61 | 7.05 | 5.45 |
| EV / EBITDA | 14.21 | 14.01 | 16.60 | 20.40 | 23.95 | 30.57 | 25.54 | 25.59 | 21.65 | 22.19 | 16.51 |
| EV / EBIT | 18.53 | 18.27 | 20.01 | 24.37 | 28.28 | 38.60 | 31.21 | 31.65 | 24.60 | 25.53 | 18.77 |
| EV / FCF | — | 18.08 | 25.19 | 28.44 | 31.45 | 37.98 | 30.07 | 32.30 | 29.34 | 26.69 | 23.31 |
Margins and return-on-capital ratios measuring operating efficiency
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 51.7% | 51.7% | 54.0% | 55.7% | 55.1% | 53.8% | 50.8% | 53.8% | 54.4% | 51.8% | 54.0% |
| Operating Margin | 28.9% | 28.9% | 33.0% | 32.8% | 31.2% | 26.3% | 29.9% | 29.6% | 30.9% | 27.5% | 29.0% |
| Net Profit Margin | 22.0% | 22.0% | 26.4% | 25.1% | 23.2% | 22.0% | 25.2% | 25.1% | 24.9% | 20.0% | 21.3% |
| Metric | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 25.5% | 25.5% | 29.1% | 30.4% | 31.7% | 33.8% | 41.7% | 47.5% | 58.9% | 49.2% | 48.0% |
| ROA | 12.6% | 12.6% | 14.3% | 13.4% | 11.7% | 12.7% | 18.6% | 20.5% | 23.7% | 18.9% | 21.2% |
| ROIC | 14.4% | 14.4% | 15.5% | 15.1% | 13.5% | 13.1% | 19.4% | 21.8% | 28.0% | 24.6% | 27.1% |
| ROCE | 20.5% | 20.5% | 20.9% | 20.4% | 17.9% | 17.3% | 25.5% | 27.9% | 34.5% | 30.4% | 34.0% |
Solvency and debt-coverage ratios — lower is generally safer
| Metric | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.77 | 0.77 | 0.71 | 0.82 | 1.14 | 1.67 | 0.85 | 0.97 | 0.85 | 1.09 | 1.03 |
| Debt / EBITDA | 1.69 | 1.69 | 1.66 | 1.84 | 2.40 | 3.67 | 1.49 | 1.62 | 1.15 | 1.36 | 1.44 |
| Net Debt / Equity | — | 0.65 | 0.56 | 0.60 | 0.87 | 1.29 | 0.18 | 0.32 | 0.32 | 0.70 | 0.68 |
| Net Debt / EBITDA | 1.43 | 1.43 | 1.30 | 1.34 | 1.84 | 2.84 | 0.32 | 0.54 | 0.43 | 0.86 | 0.95 |
| Debt / FCF | — | 1.85 | 1.98 | 1.87 | 2.42 | 3.52 | 0.37 | 0.68 | 0.58 | 1.04 | 1.34 |
| Interest Coverage | 12.80 | 12.80 | 13.80 | 10.90 | 9.81 | 13.43 | 58.03 | 44.46 | 26.38 | 22.60 | 42.94 |
Short-term solvency ratios and asset-utilisation metrics
| Metric | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.60 | 0.60 | 1.40 | 1.25 | 1.59 | 1.99 | 2.96 | 3.05 | 2.67 | 1.95 | 2.04 |
| Quick Ratio | 0.60 | 0.60 | 1.40 | 1.25 | 1.59 | 1.99 | 2.96 | 3.05 | 2.67 | 1.95 | 2.04 |
| Cash Ratio | 0.21 | 0.21 | 0.65 | 0.63 | 0.88 | 1.15 | 2.16 | 2.12 | 1.64 | 0.94 | 0.97 |
| Asset Turnover | — | 0.58 | 0.53 | 0.53 | 0.51 | 0.45 | 0.71 | 0.71 | 0.91 | 0.94 | 0.86 |
| Inventory Turnover | — | — | — | — | — | — | — | — | — | — | — |
| Days Sales Outstanding | — | — | — | — | — | — | — | — | — | — | — |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | 1.4% | 1.4% | 1.1% | 0.9% | 0.8% | 0.8% | 0.8% | 0.8% | 0.9% | 1.0% | 1.3% |
| Payout Ratio | 30.8% | 30.8% | 26.8% | 28.1% | 29.6% | 31.7% | 29.5% | 29.6% | 28.4% | 33.5% | 31.3% |
| Metric | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | 4.6% | 4.6% | 4.2% | 3.3% | 2.8% | 2.4% | 2.7% | 2.8% | 3.3% | 3.0% | 4.1% |
| FCF Yield | 6.1% | 6.2% | 4.3% | 3.8% | 3.4% | 2.9% | 3.4% | 3.2% | 3.5% | 3.9% | 4.6% |
| Buyback Yield | 5.5% | 5.6% | 2.1% | 1.4% | 1.0% | 0.1% | 1.8% | 1.5% | 2.1% | 3.4% | 4.2% |
| Total Shareholder Yield | 6.9% | 7.0% | 3.2% | 2.4% | 1.9% | 0.9% | 2.6% | 2.3% | 3.0% | 4.4% | 5.5% |
| Shares Outstanding | — | $37M | $38M | $39M | $39M | $39M | $39M | $39M | $39M | $39M | $40M |
Includes 30+ ratios · 30 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying FDS stock.
FactSet Research Systems Inc.'s current P/E ratio is 21.9x. The historical average is 29.4x. This places it at the 13th percentile of its historical range.
FactSet Research Systems Inc.'s current EV/EBITDA is 14.2x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 17.1x.
FactSet Research Systems Inc.'s return on equity (ROE) is 25.5%. This is above the typical threshold of 15-20% considered good for most companies. The historical average is 35.1%.
Based on historical data, FactSet Research Systems Inc. is trading at a P/E of 21.9x. This is at the 13th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
FactSet Research Systems Inc.'s current dividend yield is 1.37% with a payout ratio of 30.8%.
FactSet Research Systems Inc. has 51.7% gross margin and 28.9% operating margin. Operating margin above 20% indicates strong pricing power and cost efficiency.
FactSet Research Systems Inc.'s Debt/EBITDA ratio is 1.7x, indicating moderate leverage. A ratio below 2x is generally considered financially healthy.
Key Metrics
Top Statement Risk
Capital return consuming operating cash flow
Metrics are mathematically derived from official filings.
Discount to Peers Underpins Re-rating Case
Per current market data, FDS trades at 17.4x trailing earnings and 15.1x forward, against P/B of 4.74 — a book multiple that is analytically meaningless given negative tangible book value, while the 1.73 PEG suggests the market is not paying for growth acceleration.
The 17.4x trailing multiple sits well below the SPGI (26.9x), MSCI (34.6x) and TRI (28.6x) comparables, which suggests the market is discounting FactSet's structurally lower gross margin — 54.0% versus Thomson Reuters' 75.8% — and its sensitivity to buy-side headcount. The 1.73 PEG reads as reasonable only against an assumption of mid-to-high single-digit growth; with diluted EPS declining in each quarter of 2026 despite rising revenue, that assumption appears more fragile than the multiple implies, so the discount may reflect earnings quality concerns rather than a permanent valuation gap.
Eroding Returns Reflect Margin, Not Leverage
Reported quarterly figures show ROE sliding from 8.6% in 2024Q3 to 6.0% in 2026Q4 and ROA from 3.9% to 2.9%, even as subscription revenue compounded at roughly 15.5%, suggesting growth is no longer translating into higher returns on the equity base.
DuPont decomposition indicates the decline is not a leverage artifact — equity-to-assets has held broadly stable between 0.47 and 0.51 — so the compression appears driven by net income contraction rather than by equity release through buybacks, which would normally flatter ROE mechanically. With fee income accounting for effectively 100% of revenue, the ROA path to 2.9% reflects a margin problem rather than a spread or credit problem, and the persistently negative net interest income line adds a small but recurring drag on reported returns.
Thin Liquidity Bounds Capital Flexibility
Equity-to-assets of 0.48 and debt-to-equity of 0.71, per reported balance sheets, leave FactSet's leverage buffer intact but unremarkable, while the cash position has fallen 48.5% to $233.3M and securities holdings to zero, constraining flexibility for debt reduction or further large-scale M&A.
An equity-to-assets ratio of 0.48 alongside debt-to-equity of 0.71 is adequate in absolute terms but shows no visible expansionary headroom: with 2026 operating cash flow of $822.2M nearly equalled by $808M of dividends and buybacks, deleveraging capacity would appear to require moderating capital return, which has historically been management's primary shareholder-facing commitment. Investors should monitor whether repurchase pace is reduced before assuming the balance sheet can absorb further acquisitions on top of the CUSIP Global Services financing load.
Negative Margin Signal Reflects Funding Drag
Based on quarterly disclosures, net interest margin has been negative or absent in every reported period, printing -0.3% in 2026Q4, while the operating cost measure has drifted upward from 19.4% to 24.0% over two years, indicating funding costs are not abating and operating leverage is softening.
Fee income of 100.0% to 106.8% of revenue across the series confirms the business is entirely subscription-driven, so the negative NIM print appears to reflect financing costs on the post-CGS debt load rather than any lending activity — a structural drag, not a cyclical one. The upward drift in the cost ratio alongside declining EPS suggests royalty payments and technology spend are rising faster than pricing, which would be consistent with structural margin compression rather than the operating leverage management has historically guided toward.
Provision Line Outgrows Net Income
According to the company's reported financials, quarterly loan loss provisions expanded 48% from $230.1M to $340.7M over ten quarters — a trajectory that is difficult to reconcile with a subscription data business generating 100% fee income and warrants further investigation.
The size of the provision line — approximately 2.8x reported net income in 2026Q4 — is inconsistent with an asset-light model that discloses essentially no loan book, so the figure may reflect reclassification or non-operating charges rather than genuine credit exposure. Until the composition of the line is clarified, it should not be read as evidence of deteriorating asset quality, nor should it be excluded from earnings without further disclosure; both interpretations carry valuation consequences.
Book Value Ratios Obscure Real Economics
Per current pricing data, FactSet's P/B of 4.74 rests on an equity base that excludes goodwill, while tangible book value per share stands at negative $31.79 — making the price-to-book multiple analytically void and leaving earnings-based metrics as the only usable anchor.
Because goodwill and acquired intangibles from the CUSIP Global Services transaction exceed book equity — tangible book value per share has deteriorated from -$24.48 to -$31.79 over the window — P/B and P/TBV cannot distinguish a premium franchise from an impaired capital base, and cross-sectional P/B comparisons to SPGI (3.33x) or ICE (3.00x) are spurious for FDS. The appropriate anchor is forward P/E (15.1x) adjusted for non-cash intangible amortization and one-off charges, cross-checked against free cash flow yield and ASV retention durability, since earnings quality rather than book multiples is where the analytical risk actually sits.